Skip to main content
- Answer Books
- Course Handbooks
Forms & Checklists
< Back To Results
1 in 1 results
Health Care 2010: Managing Risks in the New Compliance and Enforcement Environment
Susan W. Berson, Ellen J. Flannery
Enforcement (Health care),
Health care fraud
Other versions can be found in the
PLI Item #:
CHB Spine #:
This version is not current.
Click here for the most recent version.
Add To Bookshelf
Table of Contents
Table of Contents
Chapter 1. Scientific Exchange
Chapter 2. Code of Federal Regulations, Title 21, § 312.7(a)
Chapter 3. FDA Guidance for Industry: Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices (January 2009)
Chapter 4. FDA Guidance for Industry: Industry-Supported Scientific and Educational Activities (November, 1997)
Chapter 5. Federal Trade Commission, 16 CFR Part 255, Guides Concerning the Use of Endorsements and Testimonials in Advertising
Chapter 6. Priorities for Dietary Supplement Advertising Enforcement, Remarks by David C. Vladeck, Director FTC Bureau of Consumer Protection at the Council for Responsible Nutrition’s Annual Symposium for the Dietary Supplement Industry, October 22, 2009
Chapter 7. Complaint for Civil Penalties, Injunction and Other Relief, United States v. Basic Research, L.L.C., 2:09-CV-972 (D. Utah)
Chapter 8. Pay-for-Delay Settlements, Authorized Generics, and Follow-on Biologics: Thoughts on the How Competition Law Can Best Protect Consumer Welfare in the Pharmaceutical Context, Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission at the World G
Chapter 9. Sizing Up Food Marketing and Childhood Obesity, Remarks by Chairman Jon Leibowitz, Federal Trade Commission, December 15, 2009
Chapter 10. Opinion of the Commission, In the Matter of Daniel Chapter One and James Feijo, Docket No. 9329
Chapter 11. Agreement Containing Consent Order, In the Matter of Indoor Tanning Association, No. 082-3159
Chapter 12. Analysis of Proposed Consent Order to Aid Public Comment, In the Matter of Indoor Tanning Association, No. 082-3159
Chapter 13. Complaint, In the Matter of Indoor Tanning Association, No. 082-3159
Chapter 14. Indictment, United States v. Norian Corporation Synthes, Inc.
Chapter 15. New York Codes, Rules and Regulations, Title 18, Part 521, Provider Compliance Programs
Chapter 16. New York State Social Services Law § 363-d
Chapter 17. Corporate Integrity Agreement Between the Office of Inspector General of the Department of Health and Human Services and Eli Lilly and Company
Chapter 18. Corporate Integrity Agreement Between the Office of Inspector General of the Department of Health and Human Services and Pfizer Inc.
Chapter 19. Corporate Integrity Agreement Between the Office of Inspector General of the Department of Health and Human Services and Quest Diagnostics Incorporated
Chapter 20. Legal and Ethical Issues in Clinical Studies
Chapter 21. Focus on Health Care Reform: Side-By-Side Comparison of Major Health Care Reform Proposals (Last Modified February 24, 2010)
Chapter 22. The President’s Proposal
Chapter 23. The Health Care Fraud Enforcement Juggernaut Continues: Congress Invests in Fraud Recovery Efforts to Help Reform and Strengthens the False Claims Act
Chapter 24. Health Care Fraud Alert: “Where There’s Heat, There’s Enforcement Activity”; “The Fraud Enforcement and Recovery Act of 2009: Greater Liability; Increased Resources”
Chapter 25. Health Care Fraud Alert: “Heat in Action”; “Inspector General Lays Out Five-Principle Strategy”
Chapter 26. Health Care Enforcement Defense Practice Group Advisory: “The Temperature is Changing in the Health Care Industry”
Chapter 27. Health Care Enforcement Defense Group Alert: “Senate Hearing and Proposed Legislation Focus on Health Care Fraud”
Chapter 28. Health Care Enforcement Defense Group Alert: “Obama Issues Executive Order Targeting Improper Payments and Waste”
Chapter 29. Health Care Reform Advisory: “Solidarity in a Sea of Dissent, Consistencies Between the House and Senate Bills’ Provisions Targeting Fraud and Abuse”
Chapter 30. Health Care Enforcement Defense Group Alert: “Fighting Health Care Fraud—This Time, It’s Personal”
Chapter 31. Prescribing Heavier Doses of Antitrust for Healthcare System Ailments: Curing or Killing the Patient?
Chapter 32. Client Advisory: “Raising the Bar: Evolving Expectations on Boards of Directors and Management Teams in Assuring Corporate Compliance”
Chapter 33. Client Advisory: “Transparency, Disclosure, and Sunshine: The Global Push for Stakeholder Accountability”
Chapter 34. Structuring and Organizing an Effective Health Care Compliance Program
All Contents Copyright © 1996-2021 Practising Law Institute.
About PLI PLUS
PLI Librarian Blog
PLI PLUS app
Continuing Legal Education since 1933.